Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Other Non-Current Assets (2016 - 2025)

BioCorRx (BICX) has disclosed Other Non-Current Assets for 15 consecutive years, with $41936.0 as the latest value for Q4 2025.

  • Quarterly Other Non-Current Assets changed 0.0% to $41936.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $41936.0 through Dec 2025, changed 0.0% year-over-year, with the annual reading at $41936.0 for FY2025, 0.0% changed from the prior year.
  • Other Non-Current Assets hit $41936.0 in Q4 2025 for BioCorRx, roughly flat from $41936.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $1.9 million in Q1 2021 to a low of $24429.0 in Q3 2022.
  • Historically, Other Non-Current Assets has averaged $165796.8 across 5 years, with a median of $43228.0 in 2022.
  • Biggest five-year swings in Other Non-Current Assets: surged 613.73% in 2021 and later crashed 92.22% in 2022.
  • Year by year, Other Non-Current Assets stood at $1.9 million in 2021, then tumbled by 97.67% to $44520.0 in 2022, then changed by 0.0% to $44520.0 in 2023, then decreased by 5.8% to $41936.0 in 2024, then changed by 0.0% to $41936.0 in 2025.
  • Business Quant data shows Other Non-Current Assets for BICX at $41936.0 in Q4 2025, $41936.0 in Q3 2025, and $41936.0 in Q2 2025.